HomePARKHOSPS › Filing
🔔 Get instant alerts when PARKHOSPS files quarterly results on BSE Start free trial →

Acquisition of Mehar Hospital Zirakpur

Filed: 03 Aug 2026, 09:41 IST Exchange: BSE Category: Merger/Acquisition — Acquisition of Mehar Hospital Zirakpur
Acquisition of Mehar Hospital Zirakpur - Park Medi World to acquire 100% stake in Mehar Mediserve LLP for approx. INR 107 Cr in cash - Mehar Hospital is a 150+ bed multi-super speciality facility in Zirakpur, Punjab - Acquisition aligns with Park's strategy to expand in high-potential markets and strengthen Tricity cluster - Completion expected by December 3, 2026; commissioning under Park brand by November 2026 - Transaction is earnings-accretive and aims to enhance clinical services and operational efficiency
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PARKHOSPS — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PARKHOSPS to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Park Medi World Limited

Important. The summary above is generated automatically from Park Medi World Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.